Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years
This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in ...
Read more at CDC